Sabine Vogler

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Antimicrobial Resistance

Tyrosine Kinase

Top Venues

Applied health economics and health policy

Journal of pharmaceutical policy and practice

Expert review of pharmacoeconomics & outcomes research

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis, Stefan Fischer
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Applied health economics and health policy 22 (5) (2024)
Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Verena Knoll, Jaime Espin, Aukje K Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J Wirtz, Zaheer Ud-Din Babaar
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines. Journal of pharmaceutical policy and practice 17 (Suppl 1) (2024)
Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis, Stefan Fischer
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Applied health economics and health policy (2024)
Sabine Vogler, Nina Zimmermann, Manuel Alexander Haasis, Verena Knoll, Jaime Espin, Aukje K Mantel-Teeuwisse, Dimitra Panteli, Fatima Suleman, Veronika J Wirtz, Zaheer Ud-Din Babaar
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines. Journal of pharmaceutical policy and practice 17 (Suppl 1) (2024)
Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis, Stefan Fischer
Pricing, Procurement and Reimbursement Policies for Incentivizing Market Entry of Novel Antibiotics and Diagnostics: Learnings from 10 Countries Globally. Applied health economics and health policy 22 (5) (2024)
Diana Ivonne Rodríguez Sánchez, Sabine Vogler
Shortages of Medicines to Treat COVID-19 Symptoms during the First Wave and Fourth Wave: Analysis of Notifications Reported to Registers in Austria, Italy, and Spain. Pharmacy (Basel, Switzerland) 11 (4) (2023)
Caroline Steigenberger, Friederike Windisch, Sabine Vogler
Barriers and Facilitators in Pricing and Funding Policies of European Countries That Impact the Use of Point-of-Care Diagnostics for Acute Respiratory Tract Infections in Outpatient Practices. Diagnostics (Basel, Switzerland) 13 (23) (2023)
Sabine Vogler, Maximilian Salcher-Konrad, Katharina Habimana
Interface policies bridging outpatient and hospital sectors in Europe: Can cross-sectorial collaboration in reimbursement and procurement improve access to affordable medicines? Expert review of pharmacoeconomics & outcomes research (2023)
Julian Perelman, Filipa Duarte-Ramos, António Melo Gouveia, Luis Pinheiro, Francisco Ramos, Sabine Vogler, Ceu Mateus
How do hospital characteristics and ties relate to the uptake of second-generation biosimilars? A longitudinal analysis of Portuguese NHS hospitals, 2015-2021. Expert review of pharmacoeconomics & outcomes research (2022)
Sabine Vogler, Katharina Habimana, Manuel Alexander Haasis
Purchasing medicines for the public sector: Evaluation of the performance of centralised procurement in Portugal. The International journal of health planning and management 37 (4) (2022)
Sabine Vogler, Friederike Windisch
Assessing, Pricing and Funding Point-of-Care Diagnostic Tests for Community-Acquired Acute Respiratory Tract Infections-Overview of Policies Applied in 17 European Countries. Antibiotics (Basel, Switzerland) 11 (8) (2022)
Sabine Vogler, Eveli Bauer, Katharina Habimana
Centralised Pharmaceutical Procurement: Learnings from Six European Countries. Applied health economics and health policy 20 (5) (2022)
Simona Gamba, Paolo Pertile, Sabine Vogler
The impact of managed entry agreements on pharmaceutical prices. Health economics (2020)
Sabine Vogler, Guillaume Dedet, Hanne Bak Pedersen
Financial Burden of Prescribed Medicines Included in Outpatient Benefits Package Schemes: Comparative Analysis of Co-Payments for Reimbursable Medicines in European Countries. Applied health economics and health policy 17 (6) (2020)
Sabine Vogler, Peter Schneider, Lena Lepuschütz
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation. Cost effectiveness and resource allocation : C/E 18 (1) (2020)
Margit Gombocz, Sabine Vogler
Public spending on orphan medicines: a review of the literature. Journal of pharmaceutical policy and practice 13 (2020)
Sabine Vogler, Peter Schneider, Guillaume Dedet, Hanne Bak Pedersen
Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan. International journal for equity in health 18 (1) (2019)
Sabine Vogler, Peter Schneider
Assessing Data Sources for Medicine Price Studies. International journal of technology assessment in health care 35 (2) (2019)
Nika Mardetko, Mitja Kos, Sabine Vogler
Review of studies reporting actual prices for medicines. Expert review of pharmacoeconomics & outcomes research 19 (2) (2018)